Columns

WISE-ROJAS | Hello From Outside Residential: What is Residential? What Now?

By |

It’s not anyone’s fault that treatment paths are not well-known. To be honest, I used to have the same questions about myself. Cornell students should be educated on the varying paths of mental health treatment in today’s world. Previously, I discussed what happens when you disclose wanting to end your life to a counselor and how being inpatient at a hospital works. I also talked about taking a health leave to get additional help — specifically, going to residential. However, I didn’t explicitly describe what residential was nor the path to treatment as a whole. When the Cornell community is educated on these topics, it can work to destigmatize mental health and teach others that healing is a process, not instantaneous.

Science

Weill Scientists Reach New Heights With Multiple Sclerosis Drug Treatment

By |

On Feb. 8, a new study on the multiple sclerosis drug siponimod conducted by researchers from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center was published in Nature Communications. The study analyzed the drug’s shape and interactions in the body, allowing researchers to understand how to lessen the drug’s side effects, such as heart and liver problems, during treatment for MS patients. 

Featured in Category

Team Spotlight: AguaClara — Clean Water for All

By |

Imagine waking up and opening the tap to muddy water. According to the World Health Organization, that is the predicament that 1.8 billion people worldwide find themselves in. Often water treatment plants are expensive and require too much energy to run. A team at Cornell hopes to change that. Pristine, crystal clear water is a luxury, AguaClara hopes to make it a right.